NCT07297667 2026-02-13
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Canadian Cancer Trials Group
Phase 1 Not yet recruiting
Canadian Cancer Trials Group
European Organisation for Research and Treatment of Cancer - EORTC